New hope for babies with sickle cell: liquid drug aims to stop painful attacks
Prevention
Recruiting now
This study looks at whether a liquid medicine called Xromi (hydroxycarbamide) can safely prevent painful blood vessel blockages in children aged 9 months to 2 years with sickle cell disease. About 180 children will take the medicine and be compared to a group of similar children …
Sponsor: Nova Laboratories Limited • Aim: Prevention
Last updated May 11, 2026 20:39 UTC